United States of America Ex Rel et al v. Davita, Inc. et al

  1. May 04, 2015

    DaVita To Pay Record $495M To Settle Kidney Drug FCA Suit

    DaVita Inc. said Monday it set aside $495 million as part of a tentative deal to resolve a False Claims Act whistleblower suit for allegedly bilking taxpayers for reimbursement of intentionally overused dialysis drugs, which a plaintiff's attorney called the largest settlement for an FCA case brought without government intervention.

  2. April 16, 2015

    DaVita To Settle FCA Suit After Witness Coaching Inquiry

    DaVita Inc. said Thursday it will settle a False Claims Act whistleblower suit accusing the company of bilking taxpayers by seeking reimbursement for intentionally overused dialysis drugs, nearly three months after a Georgia federal judge conducted a review to determine whether witnesses were coached into changing their testimony after discovery was reopened.

  3. January 29, 2015

    False DaVita Testimony Jeopardizing Privilege In FCA Suit

    A Georgia federal judge has ordered the review of communications between defense lawyers and witnesses in a False Claims Act suit against DaVita Inc. for allegedly seeking reimbursement on intentionally overused dialysis drugs, after finding the witnesses may have been coached to change their testimony.

  4. November 12, 2014

    DaVita Hit With Sanction Request In Kidney Drug FCA Suit

    Whistleblowers asked a Georgia federal judge on Tuesday to again sanction Davita Inc. for lying and failing to fully respond to discovery requests in a False Claims Act suit accusing the company of bilking taxpayers by seeking reimbursement for intentionally overused dialysis drugs.

  5. August 15, 2014

    Davita Calls Whistleblowers' FCA Kidney Drugs Suit Flawed

    Davita Inc. urged a Georgia federal court on Thursday to toss a whistleblower suit alleging it bilked taxpayers by seeking reimbursement for intentionally overused or wasted dialysis drugs, saying its dosing practices were objectively reasonable and can't be used to hold it liable under the False Claims Act.

  6. August 13, 2014

    Dialysis Co. Faces Sanctions For False Testimony In FCA Suit

    A Georgia federal judge granted a motion for sanctions Tuesday against DaVita Healthcare Partners Inc. in a False Claims Act suit accusing the company of bilking taxpayers by seeking reimbursement for intentionally overused dialysis drugs, finding DaVita had provided false information about a computer program used to determine dosage levels.

  7. June 02, 2014

    Ex-DaVita Staffers Fight To Keep FCA Suit Alive

    Whistleblowers on Friday pressed a Georgia federal judge to preserve their False Claims Act suit accusing DaVita Inc. of bilking taxpayers by seeking reimbursement for intentionally overused dialysis drugs, saying there is still a clear dispute over whether Medicare prohibits paying for relatively wasteful practices.

  8. May 07, 2013

    Whistleblowers Say DaVita Abusing Doc Privilege In FCA Case

    The relators in a False Claims Act suit accusing DaVita Inc. of creating waste to overbill Medicare told a Georgia federal court Monday that the dialysis service provider was abusing attorney-client privilege by labeling an excessive amount of communications as confidential.

  9. April 26, 2012

    Dialysis Co. Says Prior Deal Bars Some FCA Claims

    Global dialysis firm Gambro Healthcare Inc. urged a judge on Tuesday to block portions of a False Claims Act case in which former employees accuse it of creating waste in order to overbill Medicare, saying the lawsuit is partly preempted by a past settlement.

  10. March 02, 2012

    DaVita Can't Escape FCA Suit Over Kidney Med Charges

    A Georgia federal judge on Friday kept alive most of a False Claims Act suit brought by two former DaVita Inc. employees accusing the kidney care provider of fraudulently billing Medicare and other programs for the intentional waste of dialysis medications.